Crossmark

The prevalence and determinants of polypharmacy at age 69: a British birth cohort study

Crossref DOI link: https://doi.org/10.1186/s12877-018-0795-2

Published Online: 2018-05-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rawle, Mark James

Richards, Marcus

Davis, Daniel

Kuh, Diana
Funding

Funding for this research was provided by:

Medical Research Council (MC_UU_12019/1, MC_UU_12019/3, MC_UU_12019/4)

Wellcome Trust (WT107467)
License Information

Text and Data Mining valid from 2018-05-16
More Information

Article History

Received: 30 May 2017

Accepted: 30 April 2018

First Online: 16 May 2018

Ethics approval and consent to participate

: Ethical approval for the NSHD data collection at 68–69 years was obtained from the Queen Square Research Ethics Committee (14/LO/1073), and the Scotland A Research Ethics Committee (14/SS/1009). At each stage of data collection, written informed consent was provided by all participants.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.